Deep UV-excited fluorescence microscopy installed with CycleGAN-assisted image translation enhances precise detection of lymph node metastasis towards rapid intraoperative diagnosis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
28
09
2023
accepted:
24
11
2023
medline:
6
12
2023
pubmed:
5
12
2023
entrez:
4
12
2023
Statut:
epublish
Résumé
Rapid and precise intraoperative diagnosing systems are required for improving surgical outcomes and patient prognosis. Because of the poor quality and time-intensive process of the prevalent frozen section procedure, various intraoperative diagnostic imaging systems have been explored. Microscopy with ultraviolet surface excitation (MUSE) is an inexpensive, maintenance-free, and rapid imaging technique that yields images like thin-sectioned samples without sectioning. However, pathologists find it nearly impossible to assign diagnostic labels to MUSE images of unfixed specimens; thus, AI for intraoperative diagnosis cannot be trained in a supervised learning manner. In this study, we propose a deep-learning pipeline model for lymph node metastasis detection, in which CycleGAN translate MUSE images of unfixed lymph nodes to formalin-fixed paraffin-embedded (FFPE) sample, and diagnostic prediction is performed using deep convolutional neural network trained on FFPE sample images. Our pipeline yielded an average accuracy of 84.6% when using each of the three deep convolutional neural networks, which is a 18.3% increase over the classification-only model without CycleGAN. The modality translation to FFPE sample images using CycleGAN can be applied to various intraoperative diagnostic imaging systems and eliminate the difficulty for pathologists in labeling new modality images in clinical sites. We anticipate our pipeline to be a starting point for accurate rapid intraoperative diagnostic systems for new imaging modalities, leading to healthcare quality improvement.
Identifiants
pubmed: 38049475
doi: 10.1038/s41598-023-48319-7
pii: 10.1038/s41598-023-48319-7
pmc: PMC10696085
doi:
Substances chimiques
Alprostadil
F5TD010360
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21363Informations de copyright
© 2023. The Author(s).
Références
Sci Rep. 2019 Jul 24;9(1):10745
pubmed: 31341229
Gastric Cancer. 2020 Jul;23(4):725-733
pubmed: 32048096
Nat Commun. 2021 Aug 12;12(1):4884
pubmed: 34385460
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Mol Biosci. 2020 Oct 22;7:571180
pubmed: 33195418
IEEE J Biomed Health Inform. 2020 Sep;24(9):2473-2480
pubmed: 32011271
Sci Rep. 2020 Sep 1;10(1):14398
pubmed: 32873856
Med Image Anal. 2021 May;70:102004
pubmed: 33647784
Cancer Med. 2019 Sep;8(12):5524-5533
pubmed: 31385432
Sci Rep. 2019 Nov 15;9(1):16912
pubmed: 31729459
Cancer Res. 2020 Sep 1;80(17):3745-3754
pubmed: 32718995
JAMA Netw Open. 2019 May 3;2(5):e194337
pubmed: 31150073
Med Image Anal. 2021 May;70:102032
pubmed: 33773296
Diagn Pathol. 2021 Aug 6;16(1):71
pubmed: 34362386
Arch Pathol Lab Med. 1998 Nov;122(11):951-6
pubmed: 9822122
Nat Med. 2020 Jan;26(1):52-58
pubmed: 31907460
Eur J Surg Oncol. 2016 Aug;42(8):1236-46
pubmed: 27055944
Clin Cancer Res. 2009 Apr 15;15(8):2879-84
pubmed: 19351770
NPJ Precis Oncol. 2019 Dec 17;3:33
pubmed: 31872065
Theranostics. 2019 Apr 13;9(9):2541-2554
pubmed: 31131052
Proc SPIE Int Soc Opt Eng. 2020 Feb;11320:
pubmed: 32362707